Cochrane Summaries

Trusted evidence. Informed decisions. Better health.
Language:
English

Interventions for sexual dysfunction following treatments for cancer

Miles C, Candy B, Jones L, Williams R, Tookman A, King M
Published Online: 
25 June 2013

This review evaluated the effectiveness of randomised controlled trials (RCTs) of interventions of any kind for sexual dysfunction following cancer treatments. Sexual dysfunction (SD) is a potential complication of cancer treatment in both men and women. Eleven RCTs were identified that evaluated the effectiveness of an intervention to treat SD following treatment for cancer. Although the quality of these trials was poor, there was sufficient evidence that oral phosphodiesterase inhibitors are an effective treatment for SD in men following treatments for prostate cancer. There was insufficient evidence for the effectiveness of other identified interventions for SD following cancer treatment. There was a relative absence of trials of treatments for SD secondary to cancer treatments in women.

This record should be cited as: 
Miles C, Candy B, Jones L, Williams R, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD005540. DOI: 10.1002/14651858.CD005540.pub2
Assessed as up to date: 
17 August 2007